skip to Main Content

Ipreo IPO Brief: April 2016

Coming off the heels of a quarter that saw just six new issuers debut, the month of April marked a notable jump as seven IPOs priced for total proceeds of $2.5B. Meanwhile, the U.S.-Based 25 Index posted a gain for the second consecutive month, rising 5.61% and outperforming the S&P’s increase of 0.27% during the month. Finally, the current 6-month backlog stands at 34 issuers seeking to raise $2.9B, a substantial decline compared to the prior year period’s 57 issuers for $9.4B.

Ipreo IPO Brief: March 2016

The IPO market continued to struggle in March with just two new issuers coming to market for combined proceeds of $123.3M. Elsewhere, the U.S.-Based 25 Index jumped 14.6% during the month, coming in well ahead of the S&P 500’s 6.6% monthly gain. Finally, the current 6-month backlog stands at 41 issuers hoping to raise $6.5B, down from the prior-year’s 59 issuers for $10.1B.

Ipreo IPO Brief: February 2016

The IPO market’s hibernation finally ended in February as the second month of the year brought four new issuers to the market for aggregate proceeds of $435.7M. Elsewhere, the U.S.-Based 25 Index continued to struggle in February, posting a loss of 3.33% while the S&P posted a marginal loss of 0.41% during the month. Finally, the current 6-month IPO backlog stands at 50 issuers seeking to raise $7.3B, slightly below the 61 deals for $8.9B in the prior-year period.

Ipreo IPO Brief: January 2016

For only the third time since 2001, the new issuance market remained dormant during the month of January. While there was no shortage of IPOs expected to price in the first month of the year, large-scale global selloffs and volatile commodity markets kept the new issuance market largely at bay. Separately, the U.S. based 25 Index widely underperformed against the broader markets in January with a decline of 18.0%, while the International 25 Index dropped 16.0%. Finally, the current 6-month IPO backlog stands at 67 issuers looking to raise $9.9B.

Ipreo IPO Brief: December 2015

Representing the slowest month for the new issuance market in what was the slowest year since 2012, December brought only two debuts to the market for combined proceeds of $606.3M. Separately, the U.S.-Based 25 Index outperformed the broader market in December, posting a gain of 1.72% relative to the S&P’s loss of 1.75%during the month, while the International 25 Index gained 1.67%. Finally, the current IPO backlog rose marginally from 61 deals in November to 64 in December, but left the total expected proceeds relatively unchanged from the prior month with a current tally of $8.8B.

Ipreo IPO Brief: November 2015

Despite the markets continuing to build upon October’s gains in November, new issuance remained relatively quiet with only 11 debuts occurring during the month. Comparably, the year-ago period brought 26 new deals to the market. Meanwhile, the U.S.-Based 25 Index outperformed the broader market in November, gaining 17.95% relative to the S&P’s rise of just 0.05% during the month, while the International 25 Index grew 3.06%. Finally, the current IPO backlog fell from 71 deals in October to 61 issuers in November despite the total expected proceeds climb from $8.3B to $8.8B.

Ipreo IPO Brief: October 2015

As market conditions settled down in October after an unstable August and September, the IPO market saw thirteen new issuers enter the fray for total proceeds of $5.3B. Elsewhere, the U.S.-Based 25 Index underperformed the broader market in October, gaining 2.23% relative to the S&P’s rise of 8.30% during the month, while the International 25 Index jumped 2.35%, reversing course from the declines in September. Finally, the current IPO backlog climbed to 71 deals from the prior month’s 65 issuers, but dwindled in terms of proceeds as it looks to raise a mere total of $8.3B compared to the $13.7B seen in last month’s backlog.

Ipreo IPO Brief: September 2015

Volatile market conditions led to a slow for IPOs in September, welcoming seven issuers for total proceeds of $1.1B. Comparably, August featured eight new debuts for total proceeds of $1.4B, while 16 new issuers debuted in the year-ago period for total proceeds of $30.8B representing a year-over-year decrease of 96.5%, largely due to the presence of Alibaba’s historic debut. Separately, the U.S.-Based 25 Index underperformed the broader market in September, falling 13.3% relative to the S&P’s loss of 2.6% during the month, while the International 25 Index dropped 6.4% in a month that saw international markets playing a dramatic role in the performance of domestic markets. Finally, the current 6 month backlog stands at 65 issuers seeking to raise $13.7B, well below the prior-year period’s backlog of 101 issuers for $21.5B.

Ipreo IPO Brief: August 2015

August, typically a slow month for new issuance, welcomed eight issuers for proceeds of $1.4B, compared to the $3.2B raised across 16 new issuers in July. The Healthcare sector (3) again accounted for the majority of new deals, raising proceeds of $370.3M, and led by Aimmune Therapeutics which raised $184.0M in its public debut. Additionally, the current 6 month backlog stands at 65 issuers seeking to raise $7.6B, well below the prior-year period’s backlog of 91 issuers for $44.9B which was bolstered by Alibaba’s IPO.

Ipreo IPO Brief: July 2015

July marked a relatively slow month for IPOs, welcoming 16 issuers for $3.1B, following June’s 30 new issuances. By comparison, last year welcomed 30 IPOs for $8.9B in one of the strongest months in terms of proceeds for the year. The Healthcare sector (7) accounted for the majority of new deals, raising a total of $1.0B, while the largest deal came from Blue Buffalo Pet Products ($778.1M) of the Consumer Goods sector. Additionally, the current 6-month backlog stands at 55 issuers seeking to raise $6.4B, well below the prior-year periods backlog of 84 issuers for $40.1B which was bolstered by Alibaba’s IPO.
Back To Top